People: Concert Pharmaceuticals Inc (CNCE.OQ)
Dr. Wilfred E. Jaeger M.D. serves as Independent Director of the Company. Dr. Jaeger has served as a member of our Board since May 2006. Dr. Jaeger co-founded Three Arch Partners, a healthcare-focused investment firm, in 1993 and served as a Managing Member until December 2019. Prior to co-founding Three Arch Partners, Dr. Jaeger was a general partner at Schroder Ventures. Dr. Jaeger also serves on the board of directors of Neuronetics, Inc. and Nevro Corp., as well as numerous private companies. During the last five years, Dr. Jaeger previously served on the board of directors of Threshold Pharmaceuticals, Inc. Dr. Jaeger received a B.S. in Biology from the University of British Columbia, an M.D. from the University of British Columbia School of Medicine and an M.B.A. from Stanford University. We believe that Dr. Jaeger’s financial and medical knowledge and experience make him a key contributor to our Board.
|Total Annual Compensation, USD||48,867|
|Restricted Stock Award, USD||--|
|Long-Term Incentive Plans, USD||--|
|All Other, USD||74,074|
|Fiscal Year Total, USD||122,941|